Join Communities

Search Notes Gallery

Home / notes / General Pharmacy Unit 3 Notes – Solid Dosage Forms

General Pharmacy Unit 3 Notes – Solid Dosage Forms

NotesGallery
Nov 19, 2026 • 42 min read
General Pharmacy Source: NotesGallery

Course Code: BP102T

Unit III Overview

Unit III: Solid Dosage Forms. This unit explains powders, tablets and capsules: their classification, advantages and limitations, formulation ingredients and preparation principles.

Topics Covered – Syllabus Coverage

Required topic Coverage
Powder classification, advantages and disadvantages Sections 3.1-3.3
Powder excipients and preparation methods Sections 3.4-3.5
Dusting powders Section 3.6
Effervescent powders Section 3.7
Efflorescent powders Section 3.8
Hygroscopic powders Section 3.9
Eutectic mixtures Sections 3.10-3.11
Tablets: definition, advantages and disadvantages Section 3.12
Tablet types and examples Section 3.13
Tablet excipients and compressed-tablet preparation Sections 3.14-3.16
Moulded tablets and pills Sections 3.17-3.18
Capsules: definition, types, advantages and disadvantages Sections 3.19-3.20
Capsule sizes Section 3.21
Capsule excipients and methods of preparation Sections 3.20, 3.22-3.24

Sections 3.25-3.27 provide quality comparisons, quick revision and examination practice.

Learning Outcomes

  • Classify powders and select a suitable presentation for the intended use.
  • Explain moisture-related powder problems and distinguish them from effervescence and eutectic behaviour.
  • Describe powder preparation and geometric dilution in a clear sequence.
  • Compare tablet types, formulation functions and manufacturing routes.
  • Explain moulding of tablets and preparation of traditional pills.
  • Identify hard-capsule parts, interpret size numbers and relate fill mass to density.
  • Compare hard and soft capsules and explain their preparation stages.

Essential Terms

Term Meaning
API Active pharmaceutical ingredient
Excipient Ingredient supporting formulation or delivery
Comminution Particle-size reduction
Granulation Formation of larger aggregates from powder particles
Disintegration Breakup of a dosage unit
Dissolution Drug entering solution

The formulation principle: A usable solid dosage form needs the correct ingredient amount, uniform distribution, suitable physical properties and intended drug release.

Scope of Preparation Diagrams

Methods describe the sequence and purpose of the main operations. Actual preparation uses the specified formula, equipment and established process conditions.

3.1 Solid Dosage Forms and Powder Fundamentals

Solid dosage forms include powders, granules, tablets and capsules. Their presentation differs, but each must contain the intended dose and deliver the medicine appropriately.

A pharmaceutical powder consists of loose, dry solid particles of suitable fineness. It may contain one API or a mixture of APIs and excipients. A powder can be a final dosage form or an intermediate used to prepare tablets, capsules or other products.

Granules are aggregates of smaller powder particles. They often improve handling and flow, but their size, strength and uniformity must suit the intended product. A granule is not simply a tablet broken into pieces.

Particle Properties That Matter

  • Particle size and distribution: Influence texture, dissolution, flow and segregation.
  • Shape and surface: Affect friction, packing and the interaction between particles.
  • Bulk density: The mass occupying a bulk powder volume, including spaces between particles.
  • Flow: Affects filling sachets, capsule bodies or tablet dies.
  • Moisture behaviour: Can cause caking, sticking, degradation or premature reaction.

Surface Area and Dissolution

Reducing particle size often increases the exposed surface area and can increase dissolution rate when other conditions are comparable. It does not guarantee a faster clinical effect: wetting, aggregation, solubility and absorption also matter.

Fine is not always better: Very fine powder may flow poorly, generate dust or agglomerate. Choose fineness for the dosage form rather than making every powder as fine as possible.

Example: a topical dusting powder must feel smooth and avoid grittiness; a powder for capsule filling also needs reliable flow and filling behaviour. The same particle specification need not suit both uses.

3.2 Classification of Powders

Powders can be classified on several independent bases.

Diagram labels: Composition: simple or compound. Dose presentation: bulk or divided. Use/route: oral, topical or specialised. Behaviour: effervescent, moisture-sensitive, etc.

Explanation: A single product can belong to several categories: for example, a compound, divided, oral effervescent powder. The categories describe different attributes, not stages in manufacture.

By Composition

  • Simple powder: Contains one principal medicinal substance, with formulation ingredients where required.
  • Compound powder: Contains two or more ingredients mixed to form a preparation.

By Dose Presentation

Presentation Description Example
Bulk / multidose Several doses in one container; each dose must be measured Suitable antacid or laxative powder
Divided / single-dose Each dose separately weighed and packed An individually packed oral sachet

Bulk powders require an appropriate measuring method. Loose spoonfuls can vary with packing and density; bulk presentation is less suitable when small errors would produce a clinically important dose difference.

By Route or Application

Category Purpose
Oral powders Swallowed or taken in a suitable liquid according to directions
Powders for reconstitution Converted into a solution or suspension before use
Dusting powders Applied to the skin for an appropriate local purpose
Inhalation powders Delivered using a specifically designed inhalation device
Insufflations Fine powders introduced to a specified site with a suitable applicator
Dentifrice powders Formulated for dental cleaning
Other specialised powders Route-specific products prepared and labelled for their intended use

By Physical or Formulation Behaviour

Special categories include effervescent, hygroscopic and efflorescent preparations, and mixtures containing eutectic-forming ingredients. These descriptions identify handling or formulation issues.

By Fineness

Terms such as coarse, moderately coarse, fine and very fine are used with defined sieve or particle-size requirements. The applicable standard determines the exact classification. Do not assign universal sieve numbers without specifying the standard.

Memory trick: Classify by composition, dose, use and behaviour. Each answers a different question: what is present, how doses are supplied, where it is used and how it behaves.

3.3 Advantages and Disadvantages of Powders

Advantages

  • Flexible formulation: Ingredient amounts can be adjusted in an appropriate compounded preparation.
  • Large doses: A powder or granule sachet may be more practical than a very large tablet.
  • No tablet-breakup step: A loose powder does not first need to disintegrate as a compressed unit.
  • Possible dry-state stability: Some drugs are more stable before addition of water.
  • Alternative administration: A suitable oral powder can be dispersed or dissolved for a patient unable to swallow a tablet.
  • Local use: Powders can provide an appropriate topical or device-based presentation.

Disadvantages

  • Taste and odour: Exposed ingredients may be unpleasant; masking is more difficult than enclosing them in a suitable shell or coating.
  • Dose measurement: Bulk doses may be inaccurate if an unsuitable measuring method is used.
  • Moisture sensitivity: Powders may absorb water, cake or react during storage.
  • Segregation: Mixed particles may separate during handling, affecting dose uniformity.
  • Loss and exposure: Fine powder can adhere to equipment, escape as dust or be lost during transfer.
  • Protection limits: An ordinary powder does not provide enteric protection or controlled release simply because it is dry.

Powders Versus Granules

Feature Powder Granules
Structure Separate small particles Aggregates of particles
Flow May be poor when very fine Often improved, depending on properties
Dust Can be substantial Often lower
Segregation Sensitive to size/density differences May be reduced with suitable granulation
Preparation Size reduction and blending Additional aggregation and sizing stages

Conditional advantages: Dryness does not make every powder stable. Moisture-sensitive, volatile or light-sensitive ingredients still need suitable formulation and packaging. Likewise, faster dissolution does not prove faster therapeutic action.

3.4 Excipients Used in Powder Preparations

An excipient supports the preparation, stability, handling or administration of a powder. Selection depends on route, patient suitability, API compatibility and the function needed.

Function Purpose Examples
Diluent Provide bulk and allow measurable divided doses Lactose or another suitable filler
Adsorbent / absorbent Help retain small quantities of liquid or reduce dampness Suitable magnesium carbonate, starch or silica
Glidant Improve flow Colloidal silicon dioxide
Sweetener / flavour Improve oral acceptability Suitable sucrose or non-sugar systems
Buffer / acidulant Adjust the intended chemical environment or taste Appropriate citrate ingredients
Effervescent components Generate gas on addition of water An organic acid and bicarbonate
Wetting agent Assist wetting of poorly wettable particles Suitable surfactant
Topical base Provide a smooth, appropriate skin powder Suitable talc or starch grades

Choice of Diluent

  • It should be safe for the intended route and exposure.
  • It should not cause unacceptable chemical or physical interactions.
  • Its particle properties should support uniform mixing and dispensing.
  • Patient-specific restrictions and the relevant formulation requirements must be considered.

An adsorbent may hold a liquid on its surface; an absorbent takes liquid into its structure. In elementary dispensing descriptions the terms are sometimes used broadly. The selected material and its demonstrated performance matter more than the name alone.

Worked Example: Divided Powder Bulk

A teaching batch contains 12 sachets, each with 25 mg fictional Drug X and final powder mass 500 mg.

  • Step 1: Total API = 12 × 25 = 300 mg = 0.30 g.
  • Step 2: Total blend = 12 × 500 = 6000 mg = 6.00 g.
  • Step 3: Diluent = 6.00 – 0.30 = 5.70 g, assuming only these two ingredients.
  • Step 4: Mix by a suitable method and divide accurately; the arithmetic alone does not prove content uniformity.

Ingredient role: A filler increases bulk, a glidant improves flow and an adsorbent helps manage liquid. Do not assume that one excipient performs all three functions adequately in every preparation.

3.5 General Preparation and Mixing of Powders

Main stages in preparing a divided powder.

Diagram labels: Verify and calculate: check formula, dose basis and batch quantities. Weigh and size: weigh ingredients; reduce particles and sieve as required. Blend uniformly: use the suitable mixing method; geometric dilution when required. Divide or fill: control each individual dose quantity during division or filling. Check, pack and label: check quality; seal in suitable packaging and label for intended use. Schematic stages; equipment depends on the formula.

Explanation: The preparation is checked before dispensing. Each stage has a purpose: verify quantities, control particle properties, achieve uniform distribution and protect the finished doses.

Stepwise Procedure

  • Step 1: Review. Verify the formula, quantity, intended route, dose basis and ingredient compatibility.
  • Step 2: Calculate and weigh. Convert units, determine batch quantities and weigh each ingredient with appropriate equipment.
  • Step 3: Reduce particles. Break lumps or reduce particle size separately where needed; avoid unnecessary loss of volatile or sensitive ingredients.
  • Step 4: Sieve. Use the specified sieve to remove aggregates and obtain suitable particle properties. Avoid confusing sieving with a guarantee of dose uniformity.
  • Step 5: Blend. Mix thoroughly using the technique appropriate to ingredient proportions and properties.
  • Step 6: Divide or fill. Weigh individual doses or fill the multidose container using the controlled procedure.
  • Step 7: Check and pack. Evaluate appearance and relevant quality requirements, then package and label for the intended use.

Size-Reduction and Mixing Techniques

Technique Principle Appropriate context
Trituration Grinding or rubbing in a mortar Reduce suitable solid particles; blend powders
Spatulation Mix on a suitable surface with a spatula Small mixtures where extensive grinding is undesirable
Sifting Pass through a suitable sieve Break aggregates; assist some blending stages
Tumbling Rotate a suitable closed mixer Larger controlled blends
Pulverisation by intervention Use a suitable volatile liquid during particle reduction, then remove it as required Certain difficult-to-powder substances
Levigation Work insoluble powder with a small amount of suitable liquid Prepare smooth dispersions or pastes; not a dry-powder step by itself

Geometric Dilution

Mix the small-quantity ingredient with an approximately equal portion of diluent. Add another portion approximately equal to the current mixture and mix again. Repeat until the full diluent is incorporated. Choose the technique according to the materials’ bulk properties.

Example: 1 g ingredient plus 15 g diluent can be mixed by additions of 1, 2, 4 and 8 g diluent, producing blend masses of 2, 4, 8 and 16 g.

Segregation control: Particle size and density differences can separate a blend during transport or filling. Avoid excessive handling, use suitable particle properties and verify uniformity by the applicable control method.

3.6 Dusting Powders: Formulation and Preparation

Dusting powders are fine preparations applied externally to the skin. They may be medicated for a specified local therapeutic purpose or nonmedicated for an appropriate protective, drying or friction-reducing function.

Desirable Properties

  • Smooth, sufficiently fine and free from irritating gritty particles.
  • Non-irritant and compatible with the intended skin site.
  • Able to spread appropriately and remain suitable during storage.
  • Appropriate microbial quality and, where required, sterility.

Medical and Surgical Distinction

Ordinary medical dusting powders are intended for their stated skin use. Surgical dusting powders or products intended for sites requiring sterility need the corresponding sterile quality and suitable ingredients. An ordinary skin powder must not be assumed suitable for an open wound or surgical site.

Ingredient Functions

Component Purpose
Specified API Intended local activity
Suitable talc grade Smoothness and slip
Suitable starch Moisture handling and bulk
Other suitable base / adsorbent Support the required texture and performance

Ingredient choices are formulation-specific. A powder described as “fine” is not automatically sterile, and sterilising one raw ingredient does not demonstrate sterility of the final product.

Stepwise Preparation

  • Step 1: Verify the intended site, formulation and required microbiological quality.
  • Step 2: Calculate and weigh suitable-grade ingredients.
  • Step 3: Reduce aggregates and sieve as specified to obtain a smooth preparation.
  • Step 4: Blend uniformly, using geometric dilution for small API quantities where appropriate.
  • Step 5: Use a validated sterile process if the finished product requires sterility.
  • Step 6: Fill into a suitable protective dispenser and label For external use, with the product-specific directions.

Packaging and Use

A suitable sifter-top or other controlled dispenser supports application. The container should protect against contamination and relevant moisture exposure. Avoid creating an airborne cloud near the face; the product’s directions determine the suitable application.

Key distinction: Fineness protects comfort; microbial control protects quality. They are separate requirements and must both be considered.

3.7 Effervescent Powders and Granules

Effervescent preparations contain suitable acidic ingredients and carbonates or hydrogen carbonates that react in water to release carbon dioxide. Oral effervescent products are dissolved or dispersed in the stated volume of water before administration.

Acid-bicarbonate reaction after addition of water.

Diagram labels: Dry ingredients: acid component and bicarbonate are kept dry before use. Add water: water brings the acid and bicarbonate into contact. Effervescence: carbon dioxide is released as bubbles. Protect the dry product from unwanted moisture.

Explanation: Water allows the ingredients to interact. Carbon dioxide produces the bubbles; moisture entering a stored product can trigger the same reaction prematurely.

A simplified ionic relationship is:

H+ + HCO3− → CO2 + H2O

The complete formulation also contains the corresponding salts and any API or other ingredients.

Common Ingredients and Functions

  • Citric acid and/or tartaric acid: Supply the acid component.
  • Sodium bicarbonate: Provides bicarbonate for gas generation.
  • API: Supplies the intended medicinal effect where present.
  • Sweetener and flavour: Improve acceptability when suitable.

Citric acid and tartaric acid can be combined to obtain suitable processing and product characteristics. The required bicarbonate amount depends on acid quantity, molecular form and the permitted degree of neutralisation; a familiar ingredient ratio is not a universal formula.

Traditional Teaching Formulation

A commonly taught effervescent-granule example uses citric acid monohydrate : tartaric acid : sodium bicarbonate = 1 : 2 : 3.4 by mass.

Citric acid alone can produce a sticky mass in this traditional process; tartaric acid alone can give friable granules. Combining them supports suitable granulation. This example is not a universal ratio for all acids, hydrates or products.

For a 6.4 g batch of this illustrative three-component mixture, the parts total 1 + 2 + 3.4 = 6.4: use 1 g, 2 g and 3.4 g respectively. If an API or other ingredients are added, the complete formula and final batch calculation must be specified.

Dry Powder Preparation

  • Step 1: Verify the formula and ensure equipment and ingredients are suitable for moisture-sensitive processing.
  • Step 2: Weigh and size the acid, bicarbonate and other ingredients separately as required.
  • Step 3: Blend under controlled humidity without initiating the reaction.
  • Step 4: Divide or fill and promptly seal in protective packaging.

Wet Granulation Method

  • Step 1: Prepare a uniform dry blend.
  • Step 2: Add the specified small amount of suitable granulating liquid to produce a workable mass, controlling premature reaction.
  • Step 3: Pass the mass through a suitable screen.
  • Step 4: Dry under established conditions, then size the granules.
  • Step 5: Check residual moisture and performance, then package promptly.

Fusion / Heat Method

In a traditional fusion method, carefully controlled warming may release water associated with a hydrated ingredient, such as citric acid monohydrate, to assist mass formation. The workable mass is screened, dried and sized. Temperature and time are formula-dependent; excessive heating or wetness can damage the preparation or consume effervescent components.

Packaging principle: Protect from moisture with an appropriate tight container or barrier sachet. A desiccant may be used when suitable. Gas production during storage is a defect, not evidence of improved activity.

3.8 Efflorescent Powders: Loss of Water of Crystallisation

Efflorescence is loss of water of crystallisation from a hydrated solid under suitable conditions. The substance may become a lower hydrate or anhydrous material. The tendency depends on temperature, humidity and the particular hydrate.

Example: sodium carbonate decahydrate is a familiar efflorescent substance. Specify the hydrate: “sodium carbonate” alone does not identify how much water is present in the material.

Why It Matters in Dispensing

  • Loss or release of crystal water may change the ingredient mass and chemical form.
  • Water released during processing may make a mixture damp or interact with other ingredients.
  • A powder may change texture or cake, and its stability or handling may be affected.

Management

  • Step 1: Identify the exact hydrate and the required strength basis.
  • Step 2: Select the approved form and process conditions that minimise unwanted changes.
  • Step 3: Where a suitable anhydrous form is substituted, calculate the equivalent mass and confirm that substitution is permitted.
  • Step 4: Use suitable packaging and storage conditions and inspect for physical change.

Teaching Calculation: Hydrate Equivalence

Suppose an exercise gives molecular masses of 286 g/mol for sodium carbonate decahydrate and 106 g/mol for anhydrous sodium carbonate. Find the equivalent anhydrous mass for 2.86 g of the decahydrate.

  • Step 1: Amount of hydrate = 2.86/286 = 0.010 mol.
  • Step 2: Anhydrous equivalent = 0.010 × 106 = 1.06 g.
  • Step 3: State that this is equivalence of sodium carbonate content, not a guarantee of interchangeable formulation behaviour.

Memory trick: Efflorescent: crystal water exits. It is different from absorbing atmospheric moisture and different from producing carbon dioxide in an effervescent preparation.

3.9 Hygroscopic and Deliquescent Powders

Hygroscopic materials take up moisture from the surrounding atmosphere. Deliquescent materials absorb enough moisture under suitable humidity conditions to dissolve in the absorbed water and form a solution. Deliquescence is therefore a stronger moisture-uptake outcome than simple dampening.

A substance’s behaviour depends on environmental humidity and temperature; it need not become liquid under every storage condition.

Examples

  • Hygroscopic solid example: anhydrous sodium carbonate can take up atmospheric moisture. Its hydrate form must be distinguished from the efflorescent decahydrate.
  • Solid examples: anhydrous calcium chloride and certain other salts absorb moisture readily; calcium chloride can deliquesce under suitable conditions.
  • Choose the specific form and properties of a pharmaceutical ingredient rather than assuming all salts behave alike.

Consequences

  • Caking, dampness and reduced flow can make dose division or filling inconsistent.
  • Increased moisture can promote API degradation or other chemical reactions.
  • Mass gained from water can affect the concentration basis and measured quantities.
  • Effervescent ingredients may react if unwanted moisture is present.

Handling and Packaging

  • Step 1: Check moisture sensitivity, ingredient grade and the required formulation.
  • Step 2: Handle for the shortest appropriate period in controlled conditions.
  • Step 3: Use a suitable moisture-barrier container or sealed sachet.
  • Step 4: Use compatible moisture-management materials or desiccants only when appropriate to the product.
  • Step 5: Inspect for caking or liquefaction and follow the established quality decision if change occurs.

Ordinary paper wrapping is often insufficient for a strongly moisture-sensitive product. Packaging must control water-vapour entry, not merely prevent visible spillage.

Do not confuse the direction: Hygroscopic: moisture enters. Efflorescent: crystal water leaves. Moisture can make both preparations difficult to handle, but the underlying mechanisms differ.

3.10 Eutectic Mixtures: Melting-Point Depression

A eutectic system involves components whose mixture can melt at a lower temperature than the individual components. At the eutectic composition, a particular system has its lowest melting temperature under the specified conditions.

Some suitable mixtures of substances that are solid at room temperature can therefore soften or liquefy when combined. The outcome depends on composition and temperature. A familiar pharmaceutical example is a camphor-menthol mixture.

Mechanism and Significance

  • Mixing can change the solid-liquid equilibrium and lower the mixture’s melting temperature.
  • Liquefaction is a physical formulation problem; it does not necessarily mean a new chemical compound has formed.
  • Grinding brings the components into close contact and may accelerate observable softening.
  • A damp-looking mixture may therefore result from melting-point depression even without moisture uptake.

Handling Options

  • Step 1: Identify potentially interacting components and review the permitted formulation.
  • Step 2: If a powder is required, incorporate each component separately with an appropriate quantity of a compatible adsorbent or diluent.
  • Step 3: Combine gently by a suitable technique, avoiding unnecessary intimate grinding when it promotes liquefaction.
  • Step 4: Evaluate texture and performance and use suitable protective packaging.
  • Step 5: If the formulation intentionally uses the liquid mixture, follow that specified process rather than trying to keep it powder-like.

Possible Materials

Suitable magnesium carbonate, starch, silica or another compatible material may be considered according to the formula and route. The choice and amount must be adequate for the actual mixture; there is no universal adsorbent ratio.

Physical change versus moisture: If two dry solids liquefy after mixing, consider eutectic behaviour. If a single powder becomes wet after humid storage, consider moisture uptake. Appearance alone does not establish the mechanism; review composition and conditions.

3.11 Special Powder Behaviours: Comparison and Cases

Four powder behaviours with distinct causes.

Diagram labels: Effervescent: water + acid/bicarbonate produce carbon dioxide. Efflorescent: hydrated crystals lose water of crystallisation. Hygroscopic: atmospheric moisture enters; caking may occur. Eutectic mixture: mixing can lower melting temperature; softening may occur. Independent behaviours, not consecutive steps.

Explanation: Effervescence requires a reacting acid-base system and water; the other panels distinguish loss of crystal water, atmospheric moisture uptake and mixture-related melting-point depression.

Term Main cause Key sign / consequence
Effervescent Acid-carbonate reaction in water CO₂ bubbles; intended before administration
Efflorescent Loss of crystal water Change in hydrate, texture or water content
Hygroscopic Uptake of atmospheric moisture Dampness or caking
Deliquescent Moisture uptake sufficient for dissolution Solution formed from absorbed water
Eutectic-forming Lower mixture melting temperature Softening or liquefaction after mixing

Case 1: Sealed Sachet Develops Lumps

An effervescent sachet becomes lumpy after its seal is damaged. Explanation: moisture may enter, promote caking and start the reaction. Investigate package integrity and relevant quality requirements; simply breaking the lumps does not restore the consumed components.

Case 2: Camphor and Menthol Soften Together

Both ingredients are initially solid and become liquid after mixing. Explanation: consider melting-point depression in their mixture. This is not correctly described as “the ingredients become hygroscopic because they are mixed”.

Case 3: A Hydrated Salt Changes During Storage

A specified hydrate loses water under the storage conditions. Explanation: efflorescence may change its mass and form. Correct ingredient identity and storage matter when calculating equivalence.

Case 4: Bulk Doses Vary

A powder contains particles with very different sizes and densities. Doses taken from the top and bottom differ. Explanation: segregation is possible; suitable blending, handling, unit-dose presentation and uniformity controls must be considered.

One-line recall: Bubble, release, absorb, melt: effervescent releases gas; efflorescent releases crystal water; hygroscopic absorbs atmospheric water; a eutectic-forming mixture may melt at a lower temperature.

3.12 Tablets: Definition, Advantages and Limitations

Tablets are solid dosage units containing one or more APIs, usually with suitable excipients, prepared mainly by compression or, for appropriate products, by moulding. Shape, size, coating and release design vary.

Advantages

  • Unit dose: The patient receives a defined amount in each suitable dosage unit.
  • Convenience: Tablets are portable and often straightforward to package and count.
  • Efficient manufacture: Large numbers can be produced reproducibly with controlled equipment.
  • Protection and acceptability: Appropriate coating can improve handling, taste masking or protection.
  • Release design: Formulations can provide immediate, delayed or extended release when properly developed.
  • Dry-state presentation: May improve stability compared with some aqueous products.

Limitations

  • Some patients cannot swallow the tablet size or need another formulation.
  • Poorly soluble or poorly wettable drugs may have dissolution challenges.
  • Some powders do not flow or compact adequately without formulation changes.
  • A large dose may produce an unacceptably large tablet.
  • Moisture, light, coating failure or mechanical damage can affect quality.
  • An ordinary uncoated tablet may not mask taste or protect a stomach-sensitive API.

Desirable Properties

A tablet should have correct identity and content, suitable dose uniformity, adequate mechanical integrity and the intended disintegration or dissolution behaviour. It should remain suitable during the stated shelf life and be appropriately identifiable and labelled.

Strength has two meanings: Drug strength is the labelled API amount. Mechanical strength is resistance to breakage. A tablet can be mechanically strong yet release its API inadequately; the two are not interchangeable quality attributes.

3.13 Types of Tablets with Examples

Type Main feature Example / application
Conventional immediate-release Release without a deliberate prolonged-release design Suitable conventional paracetamol tablets
Film-coated Thin polymer film Taste masking or product protection as designed
Sugar-coated Sugar-based coating Traditional taste-masking or protective presentation
Enteric / gastro-resistant Delay release in gastric conditions Suitable enteric-coated aspirin products
Extended / prolonged release Release over an extended period Specified extended-release metformin products
Chewable Chewed before swallowing as directed Suitable antacid tablets
Dispersible Dispersed in water before use Suitable dispersible antibiotic products
Soluble Dissolve to form a solution before use Specified soluble preparations
Effervescent React in water with gas release Suitable vitamin or medicine effervescent tablets
Orodispersible Disintegrate rapidly in the mouth Specified orodispersible products
Sublingual Placed under the tongue Specified nitroglycerin tablets
Buccal Placed against cheek mucosa Specified buccal medicines
Lozenge / troche Dissolves slowly in the mouth Suitable local throat preparations
Multilayer / compression-coated Separate layers or a compressed outer region Separation of ingredients or a designed release pattern
Moulded / triturate Formed from a suitable moist mass in a mould Traditional small tablet triturates

Classification Axes

These categories are not mutually exclusive. An extended-release tablet may also be film-coated; a buccal tablet may be compressed. Classify by manufacturing method, coating, release pattern and method of use.

Important Differences

  • Film coating does not automatically mean enteric coating.
  • Dispersible means particles can form a dispersion; soluble means the preparation is intended to form a solution.
  • An orodispersible tablet is not automatically intended for sublingual absorption; some drug may be swallowed after disintegration.
  • Enteric describes delayed release in relation to gastric conditions, not necessarily sustained release over many hours.

Use the specified product directions: Do not infer chewing, crushing, splitting or dissolving instructions solely from tablet appearance. The formulation and approved product information determine the suitable administration.

3.14 Tablet Excipients and Their Functions

Class Purpose Examples
Diluent / filler Provide suitable tablet bulk Lactose, microcrystalline cellulose
Binder Promote granule cohesion or tablet integrity Povidone, suitable starch preparations
Disintegrant Support tablet breakup Croscarmellose sodium, sodium starch glycolate
Lubricant Reduce friction at die walls and during ejection Magnesium stearate
Glidant Improve flow into the die Colloidal silicon dioxide
Antiadherent Reduce sticking to tooling Suitable talc or another specified material
Wetting agent Assist contact between water and particles Suitable surfactant
Colour / flavour / sweetener Support identification or acceptability Permitted materials appropriate to the product
Coating material Protect, mask taste or control release Suitable cellulose-based polymers
Release-controlling material Modify the release pattern Appropriate matrix polymers

Formulation Balance

The binder must support tablet integrity without preventing the intended release. A disintegrant must be effective in the actual formulation. Lubricant type, quantity and mixing can affect wetting or strength. A successful formula balances these functions rather than maximising every ingredient amount.

Intragranular and Extragranular Additions

Intragranular ingredients are included before granulation. Extragranular ingredients are added after the granules are formed and sized. A disintegrant may be split between these positions; the formula specifies the appropriate arrangement.

API Properties to Consider

  • Dose, particle size, crystal form, solubility and wetting.
  • Flow, compressibility and compatibility with the selected process.
  • Sensitivity to water, heat or mechanical stress.
  • Interaction with excipients and packaging.

Three functions, three ideas: Binder joins. Disintegrant separates. Lubricant reduces friction. A glidant improves flow; it is not simply another name for a lubricant.

3.15 Preparation of Compressed Tablets

The three principal introductory routes are direct compression, wet granulation and dry granulation. The route is selected from the API and blend properties, process suitability and required product performance.

Direct Compression

  • Step 1: Verify and weigh the API and direct-compression-compatible excipients.
  • Step 2: Screen or condition ingredients as specified.
  • Step 3: Blend uniformly and add lubricant in the specified stage.
  • Step 4: Compress the blend into tablets.
  • Step 5: Inspect, test and package; coat if required by the product.

Direct compression avoids a deliberate granulation stage. It can be simple and economical, but requires a blend with suitable flow, compactability and uniformity; low-dose ingredients may still segregate.

A conventional wet-granulation sequence leading to compression.

Diagram labels: Dry blend: API + intragranular ingredients. Wet mass/granulate: add specified binder and granulating liquid. Dry: reach established moisture endpoint. Size: obtain a suitable granule-size distribution. Final blend: add extragranular ingredients and lubricant. Compress: form tablets; evaluate and package. Schematic equipment; process settings are formulation-specific.

Explanation: The granules are dried and sized before final blending. Excipients added after sizing are extragranular; the diagram does not prescribe a universal solvent, temperature or screen size.

Wet Granulation: Stepwise Explanation

  • Step 1: Weigh and dry-blend API with the intragranular ingredients.
  • Step 2: Prepare the specified binder system and add granulating liquid under controlled mixing.
  • Step 3: Form a workable wet mass and granulate or screen using the specified equipment.
  • Step 4: Dry to the appropriate moisture endpoint, protecting sensitive ingredients.
  • Step 5: Mill or screen to obtain the required granule-size distribution.
  • Step 6: Blend with extragranular ingredients and lubricant as specified.
  • Step 7: Compress, evaluate and package; apply coating if needed.

Dry Granulation

  • Step 1: Weigh and blend suitable dry ingredients.
  • Step 2: Compact into ribbons using rollers, or into larger compacts by the specified slugging process.
  • Step 3: Mill and screen the compacts into granules.
  • Step 4: Make the final blend with the specified remaining excipients.
  • Step 5: Compress into tablets, check quality and package.
Route Useful feature Limitation
Direct compression Few operations; no wetting or drying stage Requires suitable blend properties
Wet granulation Can improve granule cohesion and handling Liquid and drying may be unsuitable for sensitive APIs
Dry granulation Avoids granulating liquid Compaction history can affect later tablet formation

Granulation purpose: Granulation can improve flow, reduce some segregation risks and aid processing. It does not automatically establish content uniformity, stability or satisfactory drug release.

3.16 Tablet Compression Cycle and Quality Checks

Simplified punch-and-die cycle for a compressed tablet.

Diagram labels: Upper punch, lower punch, die walls and tablet. Fill: particles enter the die cavity. Compact: punches form a coherent tablet. Eject: lower punch raises the tablet. Schematic views; not machine dimensions.

Explanation: The die provides the cavity. Upper and lower punches compact the fill; the lower punch then raises the formed tablet for ejection. The views are schematic and do not reproduce a machine’s cam system.

Compression Stages

  • Step 1: Fill. Powder or granules enter the die cavity while the lower punch sets the available fill space.
  • Step 2: Meter. The fill quantity is controlled and excess material is removed as required.
  • Step 3: Compact. Punches apply the specified pressure; particles rearrange, deform or fragment to form a coherent tablet.
  • Step 4: Eject. The upper punch withdraws and the lower punch raises the tablet from the die.
  • Step 5: Remove. The tablet leaves the station for subsequent handling and checks.

Common Defects

Defect Meaning Possible contributors
Capping A top or bottom portion separates Air entrapment, unsuitable granules or compression conditions
Lamination Tablet separates into layers Compaction, air or formulation issues
Sticking / picking Material adheres to tooling; local surface material may be removed Moisture, inadequate lubrication or tooling condition
Mottling Uneven colour Colour distribution, migration or material differences
Chipping Edges break Weak tablet, tooling or handling conditions
Mass variation Inconsistent tablet mass Poor flow or inconsistent die filling

A defect can have several causes. Correction requires investigation of the formulation, material properties, equipment and process; one universal adjustment cannot resolve every defect.

Tests and Their Meanings

  • Identity and assay: Confirm the intended API and its amount.
  • Uniformity of dosage units: Evaluate dose consistency using the applicable method.
  • Mechanical tests: Breaking force and friability address handling resistance as appropriate.
  • Disintegration: Evaluates physical breakup under specified conditions.
  • Dissolution: Evaluates drug released into the specified medium over time.
  • Other checks: Appearance, dimensions, moisture and microbial quality where relevant.

Disintegration is not dissolution: A tablet may break into particles that dissolve slowly. Conversely, the relevant release test for a modified-release product may differ from an ordinary immediate-release disintegration requirement. Apply the product-specific criteria.

3.17 Moulded Tablets and Tablet Triturates

Moulded tablets are formed by placing a suitable moist formulation into mould cavities and allowing it to set or dry, rather than forming the unit mainly by compression. Traditional tablet triturates are small units made with a soluble diluent system and a limited amount of moistening liquid.

Features

  • They can have a porous structure and dissolve or disintegrate readily when suitably formulated.
  • Mechanical strength may be lower than that of a well-designed compressed tablet.
  • The mould and uniformity of the moist mass influence unit shape and dose distribution.
  • They are not necessarily a modern substitute for a manufactured product with demonstrated stability and performance.

Ingredients

Traditional preparations may use a suitable soluble diluent, such as lactose or sucrose, with the API and a specified moistening liquid. The exact composition depends on the product and the moulding method.

Stepwise Moulding Procedure

  • Step 1: Verify the formula and calculate the required batch.
  • Step 2: Reduce particles as appropriate and blend API with the specified diluent.
  • Step 3: Add only the required amount of moistening liquid to produce a uniform workable mass.
  • Step 4: Fill the mould cavities evenly and remove excess mass.
  • Step 5: Remove the formed units at the appropriate stage and dry under specified conditions.
  • Step 6: Check appearance, amount uniformity and relevant performance, then package to prevent damage.
Aspect Compressed tablet Moulded tablet
Main forming operation Compaction in a die Shaping a moist formulation in a mould
Material state Dry powder or granules during compression Moist or otherwise mouldable mass
Mechanical character Depends on formulation and compaction Often relatively fragile in traditional triturates
Release Depends on product design Often rapid for suitable soluble triturates

Historical terminology: Older texts may describe dispensing or hypodermic tablet triturates. Such historical names do not establish sterility or suitability for modern injection. The preparation’s actual route and quality requirements must be specified.

3.18 Pills: Traditional Definition and Preparation

In traditional pharmaceutics, a pill is a small rounded solid dosage unit prepared from a plastic, workable mass containing medicine. It is distinct from a compressed tablet. Everyday speech may use “pill” loosely, but the technical manufacturing distinction matters.

Ingredients and Mass Properties

  • API: The medicinal ingredient.
  • Diluent: Provides suitable bulk where required.
  • Binding / moistening material: Helps form a cohesive, plastic mass.
  • Dusting or finishing material: Reduces sticking or supports the specified finish where suitable.

The mass must be cohesive enough to hold its shape but not so adhesive that it sticks excessively. Suitable processing and the ingredient system determine the consistency.

Traditional pill preparation from a uniformly mixed plastic mass.

Diagram labels: Uniform ingredient mix: correct batch quantities. Plastic mass: specified binder/moistening system. Roll and divide: uniform pipe; equal portions. Round and finish: check, dry and pack as specified. Traditional pills are distinct from tablets.

Explanation: The mass is rolled and divided into equal portions before rounding. Equal portion mass supports, but does not by itself prove, uniform API content.

Stepwise Procedure

  • Step 1: Calculate the total ingredient quantities for the required number of pills.
  • Step 2: Reduce and blend the dry ingredients uniformly.
  • Step 3: Incorporate the specified binder or moistening material to obtain a suitable plastic mass.
  • Step 4: Roll into a uniform pipe or cylinder.
  • Step 5: Divide into the required number of equal portions using suitable equipment.
  • Step 6: Round each portion; dry or finish as specified.
  • Step 7: Check mass and content requirements and package appropriately.

Advantages and Limitations

Traditional pills allowed small batches and individual formulas, but uniformity, appearance and release can be difficult to control. Ageing may harden the mass and change release. Modern tablets and capsules offer more controllable manufacturing and are now more common.

Teaching Calculation

A formula requires 20 pills, each containing 10 mg fictional API.

Total API = 20 × 10 = 200 mg.

If the final pill mass is 100 mg, total mass = 2.00 g; the other ingredients together account for 1.80 g, under the stated assumptions.

Memory trick: Mix → make a mass → roll → divide → round. A tablet uses a die and punches; a traditional pill uses a shaped plastic mass.

3.19 Capsules: Definition and Classification

Capsules are dosage units in which medicine is enclosed in a suitable hard or soft shell. Shells may be made from gelatin or suitable non-gelatin materials. They may contain powders, granules, pellets or compatible liquids and semisolids.

Two-piece hard capsule and one-piece sealed soft capsule.

Diagram labels: Two-piece hard capsule: cap and body; cap overlaps the body at closure. Sealed soft capsule: shell and fill. Section illustrates the enclosed fill. Shell and fill must remain compatible.

Explanation: The hard capsule has a cap fitted over a body. The soft capsule encloses its fill in a sealed shell; the outline shows a section to illustrate the interior, not an unsealed finished product.

By Shell Construction

Type Construction Typical fill
Hard capsule Two prefabricated parts: cap and body Powders, granules or pellets; suitable liquids in appropriately sealed systems
Soft capsule Flexible sealed shell formed with the fill Compatible liquid or semisolid fill; suspended API may be included

By Shell Material

  • Gelatin shells: Protein-based shells with properties controlled by composition and processing.
  • HPMC shells: Hypromellose-based shells suitable for specified products.
  • Other suitable polymers: Available for selected shell systems, depending on product and processing needs.

By Release Pattern

  • Immediate-release: Intended to release contents without a deliberate delayed or prolonged-release design.
  • Delayed-release: Release is delayed, for example by a gastro-resistant shell or coated contents.
  • Extended / prolonged release: Release occurs over an extended period through the designed fill or shell system.

A hard capsule may contain coated pellets providing modified release. Opening the shell or changing the contents can affect administration or release suitability; product-specific directions determine what is permitted.

Shell type is not release type: A hard shell is not automatically immediate-release, and a soft shell is not automatically prolonged-release. Construction, material and release design are separate classification axes.

3.20 Capsule Advantages, Limitations and Excipients

Advantages

  • Enclose ingredients and can mask unpleasant taste during swallowing.
  • Provide a unit-dose presentation with suitable content control.
  • Allow different fill systems, including powder blends, pellets and appropriate liquid fills.
  • Can avoid the high compression forces used to make conventional tablets.
  • Permit appropriate appearance, identification and release designs.

Limitations

  • Some patients have difficulty swallowing the selected size.
  • Shells can be affected by excessive moisture, dryness, heat or incompatible fill ingredients.
  • Unsealed hard capsules are unsuitable for fills likely to leak.
  • Fill volume is limited; a large dose or low-density blend may not fit a convenient size.
  • A soft-capsule process requires specialised equipment and careful shell-fill compatibility.
  • Ordinary capsules generally do not provide accurate fractional doses by splitting the contents.

Shell Ingredients

Ingredient Function
Gelatin or suitable polymer Form the shell
Water Process the shell material and contribute to its condition
Plasticizer in suitable soft shells Provide flexibility; examples include glycerol or sorbitol systems
Permitted colour / opacifier Support appearance or light protection where appropriate
Other authorised ingredients Provide a specific needed function in the shell system

Fill Ingredients

Function Example or role
Diluent Provide bulk in a powder fill
Glidant / lubricant Support flow and machine filling
Disintegrant Help powder plugs or contents disperse where needed
Vehicle / solvent Carry compatible dissolved or dispersed API in a liquid fill
Wetting / suspending ingredient Improve the specified dispersion
Stabilising ingredients Control relevant oxidation or other degradation
Release-controlling system Coated pellets or other validated release design

Shell-fill compatibility: A fill that is strongly moisture-absorbing, water-rich, volatile or chemically reactive may damage a particular shell or alter release. Suitability depends on the actual shell and formulation; neither “liquid” nor “powder” alone decides compatibility.

3.21 Capsule Sizes and Fill-Capacity Calculations

Conventional two-piece hard capsules commonly use the size sequence 000, 00, 0, 1, 2, 3, 4 and 5. Within this standard series, 000 is largest and 5 is smallest. Extended sizes and other specialised designs also exist.

Relative size order for common hard-capsule sizes.

Diagram labels: Larger: 000 → 00 → 0 → 1. Then: 2 → 3 → 4 → 5, smaller. Relative order only; not an engineering scale.

Explanation: The outlines show the decreasing size order; they are schematic rather than engineering dimensions. Size numbers identify shell formats, not a fixed API mass.

Illustrative Volume Capacities

The following are approximate capacities from one commonly supplied specification set. Dimensions and capacity vary by manufacturer and shell design; use the chosen shell’s current specification for formulation or equipment settings.

Size Approximate capacity (mL)
000 1.37
00 0.90
0 0.68
1 0.48
2 0.36
3 0.27
4 0.20
5 0.13

Volume Is Not a Fixed Mass

Estimated fill mass (g) = usable volume (mL) × effective filling density (g/mL)

Density includes packing behaviour under the filling conditions. Bulk and tapped density give useful information but may not exactly reproduce a machine’s fill density.

Worked Example: Size 0

  • Step 1: Use an illustrative capacity of 0.68 mL and an assumed effective density of 0.60 g/mL.
  • Step 2: Estimated blend mass = 0.68 × 0.60 = 0.408 g = 408 mg.
  • Step 3: If the blend contains 25% w/w API, estimated API per filled capsule = 408 × 0.25 = 102 mg.
  • Step 4: Verify the actual fill and content by the specified process controls. The estimate does not establish a universal capacity or prescribe a dose.

Selecting a Size

  • Calculate required API and total fill mass, including excipients.
  • Estimate volume from the appropriate blend density.
  • Choose a suitable shell volume and compatible filling equipment.
  • Consider swallowing acceptability and confirm the actual fill performance.

Memory trick: More zeros, more room; higher positive number, smaller shell. A “500 mg capsule” describes a product’s labelled amount, not a universal capsule-size specification.

Numerical Answer Format

Write the supplied quantities and units, identify whether the calculation concerns API, total fill or excipient mass, show the relationship and check the final amount. State any assumed density or capacity.

3.22 Manufacture of Empty Hard-Capsule Shells

A two-piece hard shell is generally manufactured separately from the later filling operation. The body holds the fill; the slightly larger cap fits over it.

Dipping Process

  • Step 1: Prepare shell solution. Prepare the specified gelatin or polymer system and relevant permitted ingredients.
  • Step 2: Dip. Dip cap and body mould pins into the shell-forming liquid under controlled conditions.
  • Step 3: Distribute. Withdraw and rotate or otherwise handle the pins to obtain a suitable film.
  • Step 4: Dry. Dry under controlled conditions until the shell meets the required properties.
  • Step 5: Strip. Remove the dried shell parts from the pins.
  • Step 6: Trim. Cut to the specified cap and body lengths.
  • Step 7: Join and inspect. Assemble the empty shell parts, inspect and package for the filling operation.

Controlled Attributes

  • Shell dimensions and wall properties must match the size and equipment.
  • Moisture condition influences flexibility, brittleness and storage behaviour.
  • Appearance, integrity and microbial quality must be appropriate.
  • The cap-body design may include features supporting alignment and locking.

Non-gelatin materials may require different process conditions and additional formulation components. The dipping principle is an introductory outline, not a universal recipe for every shell material.

Separate operations: Shell making creates the empty container. Capsule filling places the specified medicine inside. Confusing the two misses important material and process controls.

3.23 Preparation and Filling of Hard Capsules

Main sequence for filling prefabricated hard-capsule shells.

Diagram labels: Prepare suitable fill: uniform blend, granules or pellets. Separate shell parts: hold cap and body correctly. Fill the body: controlled amount and packing. Close/lock/seal: as required by the product. Check and package: integrity, content and release.

Explanation: The cap and body are separated, the body receives a controlled amount of fill, and the cap is replaced and secured. Appropriate mass and content checks follow filling.

Stepwise Filling Procedure

  • Step 1: Verify the formula, capsule count, shell type, size and equipment.
  • Step 2: Weigh the API and excipients and prepare a uniform blend, granulate or pellet fill as required.
  • Step 3: Condition and load suitable empty shells and separate caps from bodies.
  • Step 4: Fill each body using the specified controlled method.
  • Step 5: Replace and lock the caps; seal when the formulation or product design requires it.
  • Step 6: Clean the external surface, inspect and reject damaged or improperly filled units.
  • Step 7: Carry out the required quality checks and package protectively.

Filling Methods

Method Principle
Manual / small-scale equipment Bodies held in a plate and filled with a controlled blend; uniformity must be verified
Dosing-disc / tamping Powder is compacted into suitable plugs in dosing bores and transferred into bodies
Dosator A measured powder plug is formed in a dosing tube and transferred
Pellet filling A controlled amount of pellets is delivered into the body
Liquid filling A compatible liquid is metered into a suitable shell and appropriately sealed

Small-Scale Powder Filling

Uniform packing and consistent filling technique are important. Simply dipping a capsule body into powder until it looks full does not demonstrate a correct dose, especially with a low-dose API. The procedure needs appropriate weighing or calibrated filling and quality verification.

Batch Calculation

An exercise requires 30 capsules, each containing 50 mg fictional API and 250 mg total fill.

  • Step 1: API required = 30 × 50 = 1500 mg = 1.50 g.
  • Step 2: Total blend = 30 × 250 = 7500 mg = 7.50 g.
  • Step 3: Combined excipients = 7.50 – 1.50 = 6.00 g, under the stated assumptions.
  • Step 4: Check theoretical API fraction = 1.50/7.50 × 100 = 20% w/w.

Actual recovery and any authorised batch adjustment follow the specified procedure.

Fill mass versus capsule mass: The gross mass includes the shell. Fill mass = filled capsule mass – empty shell mass, using the appropriate method. Similar gross masses do not automatically demonstrate uniform API content.

3.24 Soft Capsules: Formulation and Manufacture

Soft capsules have a flexible, sealed shell surrounding a compatible fill. The shell is formed, filled and sealed as part of the encapsulation process. Gelatin soft capsules commonly use a suitable plasticizer to achieve flexibility.

Fill Suitability

  • Compatible oils or other vehicles can carry dissolved or suspended API.
  • Suspended particles require a suitable dispersion and controlled distribution.
  • The fill must not cause unacceptable water transfer, shell softening, brittleness, leakage or chemical interaction.
  • Volatile constituents, extremes of pH or reactive ingredients require careful compatibility assessment.
Simplified rotary-die soft-capsule production.

Diagram labels: Prepare shell/fill: compatible shell mass and uniform fill system. Form two ribbons: cast shell material into two continuous ribbons. Meter, form and seal: rotary dies form capsules around the metered fill. Dry/condition: obtain the required shell properties. Inspect and package: evaluate seals, fill amount and product quality. Shell mass; fill; shell ribbons; metered fill; die; drying chamber. Schematic stages; not a machine construction drawing.

Explanation: Two shell ribbons and a metered fill converge at the die operation. The capsules are formed and sealed, then dried and inspected. The diagram shows process relationships rather than machine engineering.

Rotary-Die Method: Stepwise Outline

  • Step 1: Prepare shell mass. Prepare the specified shell-forming system, including suitable plasticizer and water, and remove entrapped air as required.
  • Step 2: Prepare fill. Produce a uniform compatible solution or dispersion with the intended API concentration.
  • Step 3: Form ribbons. Cast continuous shell ribbons of suitable thickness.
  • Step 4: Meter and encapsulate. Feed the ribbons toward the rotating dies and deliver the controlled fill between them.
  • Step 5: Seal and separate. Form the capsule shape, seal the edges and separate the units.
  • Step 6: Dry / condition. Use the established drying sequence to obtain the required shell condition.
  • Step 7: Inspect and pack. Evaluate seals, appearance, fill amount and other relevant quality attributes.

Other Methods

Traditional plate moulding and reciprocating-die methods also form and seal suitable shell sheets around a fill. Seamless techniques can form selected spherical capsules by controlled co-delivery of shell and fill. Suitability depends on the intended product and equipment.

Hard Versus Soft Capsules

Aspect Hard capsule Soft capsule
Shell construction Usually two prefabricated parts Sealed flexible shell
Typical fill Powders, granules or pellets Compatible liquids or semisolids
Main sequence Make shell, then fill Form, fill and seal together
Flexibility Controlled by material and moisture Commonly adjusted with plasticizer
Main concerns Fill uniformity and closure Shell-fill compatibility, seal and conditioning

A liquid fill is not always a solution: The API may be dissolved or suspended in the vehicle. A uniform fill composition and correct metering are needed in both cases.

3.25 Quality, Packaging and Solid-Form Comparisons

Capsule Quality Checks

  • Appearance and integrity: No unacceptable cracks, leaks, deformation or faulty closure.
  • Identification and assay: Correct API and specified amount.
  • Dosage-unit uniformity: Appropriate mass or content-based assessment as required.
  • Release: Disintegration or dissolution under the applicable product requirements.
  • Additional attributes: Moisture, microbial quality, stability and seal performance where relevant.

Gelatin cross-linking or changes in shell condition can alter release. A visible shell change or failed release test requires the specified investigation; do not assume that a capsule is acceptable merely because the fill is still present.

Packaging and Storage

  • Protect moisture-sensitive powders with a suitable moisture barrier.
  • Protect tablets from breakage and relevant light or moisture exposure.
  • Protect capsules from excessive moisture or dryness that may damage the shell.
  • Use the specific product’s storage requirements; a generic temperature or shelf life is not valid for every formulation.
  • Label identity, strength, directions, required precautions and traceable product information appropriately.
Feature Powder Tablet Capsule
Main presentation Loose particles Formed solid unit Fill enclosed by shell
Dose supply Bulk or individual Usually unit dose Usually unit dose
Taste masking Often difficult Possible through coating/design Possible through enclosure
Main forming process Blend and fill Compress or mould Fill hard shell or form/fill/seal soft shell
Key physical concern Segregation and moisture Mechanical integrity and release Shell-fill compatibility and release

Applied Cases

  • A tablet passes assay but fails dissolution: correct API amount does not establish correct release.
  • Hard capsules have similar total mass: shell variation and uneven blend composition can still affect API content.
  • A soft capsule leaks: investigate sealing, shell properties, fill compatibility and storage conditions.
  • A powder sachet is intact but the blend has segregated: packaging does not reverse the earlier loss of uniformity.

Quality is a combination: Correct amount + uniform distribution + suitable integrity + intended release + stability. One successful test cannot substitute for all the other applicable requirements.

3.26 Quick Revision and Memory Aids

Powder Recall

  • Powder: loose dry particles. Granules: particle aggregates.
  • Simple / compound: composition. Bulk / divided: dose presentation.
  • Dusting: fine external-use preparation; required sterility depends on intended site and product.
  • Effervescent: acid and bicarbonate/carbonate produce CO₂ in water.
  • Efflorescent: lose crystal water. Hygroscopic: take up atmospheric moisture.
  • Deliquescent: moisture uptake produces a solution. Eutectic: the mixture has a lower melting temperature.

Tablet Recall

  • Direct compression: suitable dry blend → tablet.
  • Wet granulation: dry blend → wet mass → granules → dry and size → final blend → tablet.
  • Dry granulation: blend → compact → mill/size → final blend → tablet.
  • Compression: fill, meter, compact, eject and remove.
  • Moulded tablet: mould a suitable moist mass. Pill: shape a plastic mass into rounded units.
  • Binder joins; disintegrant breaks up; lubricant reduces friction; glidant improves flow.

Capsule Recall

  • Hard capsule: cap and body made separately, then filled.
  • Soft capsule: formed, filled and sealed together.
  • Size order: 000, 00, 0, 1, 2, 3, 4, 5 from larger to smaller in the conventional series.
  • Estimated fill mass: volume × effective filling density.
  • API per unit: total fill mass × API mass fraction.

Five Important Comparisons

Pair Essential difference
Effervescent / efflorescent Gas-forming reaction / loss of crystal water
Hygroscopic / eutectic Moisture uptake / mixture melting behaviour
Binder / disintegrant Support cohesion / support breakup
Disintegration / dissolution Unit breakup / drug entering solution
Mass uniformity / content uniformity Amount of preparation / amount of API

Preparation sequence: Verify → calculate → weigh → process → check → pack. The process stage differs with the dosage form; the need for verification and suitable quality control remains.

One-minute recall: Name four powder behaviours, three tablet manufacturing routes, two hard-capsule parts and the largest and smallest conventional capsule sizes. Explain why correct tablet mass does not prove correct API content.

3.27 Possible Examination Questions and Answer Guides

Examination practice: Questions follow the supplied syllabus and are practice items, not predictions. Fictional quantities and assumed capacities illustrate calculations.

Very Short-Answer Questions

  • Define powder, granule, dusting powder, efflorescence and eutectic mixture.
  • Distinguish hygroscopic from deliquescent materials.
  • Define a tablet, moulded tablet, traditional pill and capsule.
  • Name a binder, disintegrant, lubricant and glidant.
  • Name the parts of a hard capsule and list common capsule sizes in decreasing order.

Short-Answer Questions

  • Classify powders and give suitable examples.
  • Explain the advantages and disadvantages of powders.
  • Describe geometric dilution and explain segregation.
  • Describe dusting powder ingredients, preparation and packaging.
  • Explain effervescent ingredients and preparation methods.
  • Explain handling of efflorescent, hygroscopic and eutectic-forming ingredients.
  • Classify tablets with examples and distinguish enteric from extended release.
  • Compare direct compression, wet granulation and dry granulation.
  • Explain the compression cycle and common tablet defects.
  • Describe moulded tablets and traditional pill preparation.
  • Compare hard and soft capsules and explain capsule-size selection.

Long-Answer Questions

  • Discuss powders: classification, special behaviours, advantages, excipients, preparation and packaging.
  • Explain tablets: definition, types, advantages and disadvantages, excipients and manufacturing methods.
  • Describe the preparation of moulded tablets and pills, with a comparison to compressed tablets.
  • Discuss capsules: classification, advantages and limitations, shell/fill ingredients, sizes and preparation of hard and soft forms.

Application and Calculation Practice

Question Answer / key point
1. Twelve sachets contain 20 mg API and 400 mg total blend each. Find batch API and diluent. API 0.24 g; diluent 4.56 g
2. A capsule holds 0.50 mL at density 0.70 g/mL. Find total fill. 0.35 g = 350 mg
3. That 350 mg fill contains 20% w/w API. Find API per capsule. 70 mg
4. Twenty pills contain 15 mg API each. Find total API. 300 mg
5. A 2 g ingredient is mixed with 30 g diluent. Find final % w/w. 6.25% w/w
6. Dry camphor and menthol become liquid when mixed. Explain. Mixture-related melting-point depression
7. An effervescent sachet reacts during storage. Identify likely issue. Unwanted moisture entry or process moisture
8. Capsule gross mass is 320 mg; shell mass is 70 mg. Find fill mass. 250 mg
9. Similar tablet masses but variable API content: possible reason? Uneven blend or segregation; test content
10. A patient asks to crush an extended-release tablet. What governs the answer? Product-specific instructions and release design

Answer Guide: Powder Essay

Define powder, classify on clear bases, explain advantages and limitations, then describe ingredient functions and preparation steps. Compare the special powder behaviours and finish with packaging and relevant quality checks.

Answer Guide: Tablet or Capsule Essay

Start with definition and classification. Link ingredient functions to the chosen preparation method. Draw and label the useful process or structure, explain each step and conclude with the appropriate quality requirements.

Exclusive Student Alerts

Join AKTU VIP Telegram & WhatsApp Group

Get immediate exam updates, syllabus changes, quantum PDFs, and viva questions.

Have Questions or Want to Discuss?

Join the community conversation or ask your queries in the comments.

View Comments & Discussion →
Home Notes Syllabus PYQs Quantum